CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vitrafy Life Sciences Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vitrafy Life Sciences Ltd
TAS  7004  Australia Ticker: VFYVFY

Business Summary
Vitrafy Life Sciences Limited is an Australia-based company focused on the advancement of biomedical cryopreservation. It is engaged in research, development and commercialization of its vertically integrated cryopreservation solution that includes cryopreservation medical devices (freezer, thawer and packaging solutions), LifeChain integrated software system, and application services for identified application areas in human health and animal health services. Its patented algorithm calculates the required operating conditions for biomaterial cryopreservation and informs the cryopreservation technologies' automation software of precise operating conditions to deliver optimum cell survivability. Its Lifechain software platform combines the advanced software functions, such as artificial intelligence (AI), machine learning and IoMT integration, to ensure supply chain processes are controlled, traced, tracked and monitored to the standards, and retain the quality of precious biomaterials.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20246/30/2024-----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Non-Executive Chairman of the Board Sonia A.Petering 3/1/2023 3/1/2023
Chief Executive Officer, Managing Director, Executive Director KathrynMunnings 57 10/1/2024 10/1/2024
Deputy Chief Executive Officer, Co-Founder, Executive Director Brenton M.Owens
4 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 63,849,674 (As of 11/22/2024)
Stock Exchange: ASX


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 22, 2024